Patrick Terminals – Sydney AutoStrad Migrates to N4 to Advance Automation Capabilities
Terminal continues to modernize its operations to meet the growing trade demand in the region…
6 years ago
Wire Stories
Mary Kay Inc. COVID-19 Support Efforts Target Disproportionately Effected Native American Populations Through the Indian Health Service Network
DALLAS--(BUSINESS WIRE)--Earlier this year, in an effort to help slow the spread of the COVID-19…
6 years ago
Silicon Valley Investor Asha Jadeja Pledges $1 Million Seed Fund for Non-profit Start-up Accelerator
- Influential Venture Capitalist Teams with Indian Institute of Technology Alumni to Fuel Start-up Accelerator…
6 years ago
CANbridge Pharmaceuticals Receives Chinese Marketing Approval for Hunterase® First Enzyme Replacement Therapy for Hunter Syndrome in China
BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--CANbridge Pharmaceuticals Inc., a company developing and commercializing innovative drugs to…
6 years ago
New Research of Cyber Readiness During the Pandemic Reveals Security Gaps and the Need for New Solutions
As Acronis Cyber Protect 15 is released, new global research reveals that 31% of companies…
6 years ago
Behavox Appoints Gagan Gulati as Chief Product Officer
Accomplished Microsoft Veteran Will Lead Product Strategy, Roadmap and Engineering for Behavox NEW YORK--(BUSINESS WIRE)--Behavox,…
6 years ago
Renesas Introduces DDR5 Data Buffer for High-Performance Server and Cloud Service Applications
High-Speed, Low-Power Data Buffer Delivers Improved Speed and Bandwidth for DDR5 DRAM and Storage Class…
6 years ago
D&D Pharmatech Announces Launch of Valted Seq Subsidiary Focusing on Discovery of Neurodegenerative Disease Pathways and Biomarkers to Support Development of New Therapeutics and Diagnostics
Valted Seq has created the world’s largest repository of single-cell sequencing data from the brain…
6 years ago
BeiGene Announces Acceptance and Priority Review by Health Canada of New Drug Submission for BRUKINSA® (zanubrutinib) in Waldenström’s Macroglobulinemia
CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)--$BGNE #BGNE--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company…
6 years ago
Apros Therapeutics Announces IND Clearance from U.S. FDA to Initiate the Trial of APR003, an Orally-Administered Gastrointestinal/Liver-Targeted TLR7 Agonist for Treatment of Advanced Colorectal Cancer (CRC) with Malignant Liver Lesions
SAN DIEGO--(BUSINESS WIRE)--Apros Therapeutics, Inc., a drug discovery and development company focused on tissue-targeted Toll-Like…
6 years ago